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Abstract Primary enteric-type adenocarcinoma of the urinary bladder is relatively uncommon. We present
our experience with 109 pure, non-urachal cases—the largest series to date. This work was undertaken with
the aim of describing the immunohistochemical features of adenocarcinoma of the urinary bladder associ-
ated with schistosomiasis, illustrating their histologic and immunohistochemical similarities to colorectal
carcinomas. Partial or total cystectomy specimens from a cohort of Egyptian and American patients with the
diagnosis of primary adenocarcinoma of the urinary bladder (109 cases) were reviewed. Paraffin sections
of each tumour were stained using the labelled streptavidin–biotin method using antibodies cytokeratin
20, cytokeratin 7, CDX2, MLH1, and villin. Clinical follow-up was available for at least 36 months. An
enteric (colonic) morphology was seen in most tumours; some with signet ring cells or mucinous elements.
Five tumours were composed predominantly of signet ring cells and two demonstrated a pure mucinous
morphology. In cases where adjacent normal mucosa was present, 23% showed either colonic metaplasia
or intestinal-type cystitis glandularis. Furthermore, 24% of enteric-type adenocarcinomas had associated
villous or tubulovillous adenomas with or without dysplasia. Cytokeratin 20 was expressed by 90%, cytok-
eratin 7 by 17%, CDX2 by 100% and villin and MLH1 by 76% and 48% of tumours respectively. The
majority of tumours presented with an advanced stage and followed an aggressive clinical course.
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lly similar – if not identical – to colonic adenocarcinoma. The frequent asso-
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Table 2 Clinical stage and survival of 109 patients with primary
intestinal-type adenocarcinoma of the urinary bladder (minimum of
36 month follow-up).
Stage Total NEDa AWDa DODa
T1 11 (10%) 9 2 0
T2 20 (18%) 9 10 1
T3 76 (70%) 17 28 31
T4 2 (0.2%) 0 0 2
109 35 40 34
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ntroduction
rimary non-urachal enteric adenocarcinomas of the urinary blad-
er are rare and usually associated with chronic irritation of the
ladder mucosa on a background of intestinal metaplasia and/or
ntestinal-type cystitis glandularis [1–6]. The histologic similarity of
uch adenocarcinomas to colorectal carcinoma is striking. Numer-
us immunohistochemical stains have been reliably performed on
araffin embedded tissue sections and used as markers of tumour
ifferentiation as well as markers of carcinogenic mechanisms.
In this study we present a review of the morphology and
mmunophenotype of 109 such cases, mostly associated with schis-
osomiasis. In our analysis special attention was paid to the presence
f intestinal metaplasia and/or preneoplastic changes of the urinary
ladder mucosa. The results were compared with the phenotype of
olonic carcinoma previously reported.
atient and methods
ne hundred and nine partial or radical cystectomy specimens from
he National Cancer Institute, Cairo, Egypt (101 cases), and the
niversity of Miami, Jackson Memorial Hospital, Miami, FL, USA
8 cases) were examined in this study. Biographic data and clini-
al information including clinical presentation, type of therapy and
ollow-up were reviewed. The histopathology of tumour and patho-
ogic stage were recorded in all samples. Special attention was paid
o the status of non-involved bladder mucosa for the presence of
ntestinal metaplasia and/or cystitis glandularis. Two representative
araffin blocks from each case were selected for immunohistochem-
cal studies.
Paraffin sections, 4m thick, were stained using the standard
abelled streptavidin–biotin method using antibodies against cytok-
ratin 20, cytokeratin 7, CDX2, MLH1 and villin. The commercial
ources and working dilutions of the antibodies are summarised
n Table 1. Heat-induced antigen retrieval was used with cit-
ate buffer in a vegetable steamer. DAB, in the presence of
ydrogen peroxide, was used as the chromogen. All buffers and
etection reagents were from Dako (Carpinteria, CA, USA). For
DX2 and MLH1, a cytoplasmic counterstain was utilised (Fast
reen). The presence, pattern and intensity of immunohistochemi-
al reactions were evaluated in tumour cells and in non-neoplastic
pithelium.
esultsf the 134 patients with the diagnosis of adenocarcinoma, 20
atients, who did not have adequate clinical information to exclude
he possibility of urachal or metastatic colonic adenocarcinoma were
liminated. Similarly, two patients with clear cell (mesonephric)
denocarcinoma and three with extension of prostatic adenocarci-
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Table 1 The sources and working dilutions of antibodies.
Antibody Source
Cytokeratin 7 Dako (Carpinteria, CA, U
Cytokeratin 20 Dako (Carpinteria, CA, U
CDX-2 Biogenex (San Ramon, C
MLH1 Zymed (South San Franc
Villin GeneTex (San Antonio, TNED: alive, no evidence of disease; AWD: alive with disease; DOD: dead
f disease.
oma to the bladder were excluded from the study. The remaining
09 tumours occurred predominantly in trigone, lateral or postero-
ateral walls. None of the tumours involved the bladder dome.
The study cohort consisted of 68 male and 41 female patients
male/female ratio, 1.7:1.0), aged 25–78 (mean, 50.3 years). The
ost frequent presenting symptoms were haematuria and uri-
ary irritation. In most patients, partial or radical cystectomy was
erformed followed by radiation therapy. Follow-up data for a min-
mum of 36 months was available. The clinical stage of disease and
he follow-up data are summarised in Table 2. Briefly, 78 patients
72%) presented with advanced disease (T3 and T4), 61 of whom
78%) were either deceased from the disease or alive with recurrent
ancer during the follow-up period. All five patients with the pre-
ominant signet ring cell type adenocarcinoma were dead of disease
n less than 15 months following the initial diagnosis.
Tumours grossly appeared as exophytic, papillary, solid, or infil-
rative (Fig. 1A). Ulceration was grossly present in 49 cases. A linitis
lastica-like diffuse transmural infiltration was seen in two cases.
Histologically, most tumours were composed of pseudostrati-
ed columnar epithelium forming glands that resembled colonic
denocarcinoma (Fig. 1B). The histologic subtypes of tumours are
ummarised in Table 3. Focal mucinous morphology, in which small
ests of tumour cells floated in abundant extracellular mucin, was
een in 13 cases (Fig. 1C). Two tumours were of the purely muci-
ous type. Focal signet ring cell morphology was present in 15
ases. There were also five cases composed predominantly of signet
ing cells (Fig. 1D); two with a linitis plastica-like transmural infil-
ration. There were two cases showing true mixed patterns. One
as a combination of small cell carcinoma and signet ring cell
arcinoma, each comprising about 50% of the tumour mass. The
ther was a combined tumour (collision) between an intestinal-
ype adenocarcinoma (70% of the tumour mass) and a transitional
ell carcinoma. Calcified schistosoma eggs were identified in more
han 90% of the Egyptian cases, either in the midst of the tumour
r in uninvolved bladder wall. No specific histologic differences
ere observed between the cases retrieved from the Egyptian and
merican series.
Working dilution
SA) 1:200
SA) 1:25
A, USA) 1:100
isco, CA, USA) 1:20
X, USA) 1:100
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Figure 1 (A) Macroscopic view of a primary intestinal-type adenocarcinoma of the urinary bladder. (B) Gland forming adenocarcinoma of the
nocar
, 50×urinary bladder. Morphologically this tumour resembles a colonic ade
Intestinal adenocarcinoma of the urinary bladder, mucinous type (H&E
bladder (H&E, 200×).Of the 52 cases with adjacent mucosa not involved by tumour, 12
(23%) showed enteric (colonic) metaplasia of the surface mucosa,
or an intestinal-type cystitis glandularis. Further, in 24% of cases,
villous or tubulovillous adenomas with varying grades of dysplasia
a
a
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Figure 2 (A) Villous adenoma of the urinary bladder associated with
Diffuse cytokeratin 20 expression papillary areas of intestinal adenocarcino
type intestinal adenocarcinoma of the urinary bladder. Positive reaction for c
Expression of cytokeratin 7 by the urothelial (right) and not by the intestinalcinoma. Note a calcified schistosoma egg (arrow) (H&E, 100×). (C)
). (D) Signet ring cell type of intestinal adenocarcinoma of the urinarynd/or intramucosal carcinoma were present adjacent to the invasive
denocarcinoma (Fig. 2A).
Immunohistochemically, 100 tumours (92%) were positive for
ytokeratin 20; the reactions were predominantly strong and diffuse
areas of intramucosal adenocarcinoma on the left (H&E, 50×). (B)
ma of the urinary bladder (immunoperoxidase, 100×). (C) Mucinous
ytokeratin 20 in floating tumour cells (immunoperoxidase, 50×). (D)
(left) cystitis glandularis (immunoperoxidase, 100×).
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Figure 3 (A) Tubulovillous adenoma of the urinary bladder with strong nuclear staining for CDX2 (immunoperoxidase, 50×). (B) Expression of
CDX2 in a high-grade enteric adenocarcinoma of the urinary bladder (immunoperoxidase, 50×). (C) Villin expression is limited to the brush borders
of some tumour cells in a low-grade enteric adenocarcinoma of the urinary bladder (immunoperoxidase, 100×). (D) Cytoplasmic localisation
of villin in a high-grade adenocarcinoma (immunoperoxidase, 50×). (E) MLH1 expression is preserved in a villous adenoma of the urinary
bladder (immunoperoxidase, 50×). (F) Marked reduction in expression of
(immunoperoxidase, 50×).
Table 3 Morphologic variants of intestinal adenocarcinoma of the
urinary bladder.
Histologic pattern Number
Enteric (colonic) type 100
Focally mucinous type 13
Focally signet ring type 15
Pure mucinous type 2
Pure signet ring type 5
Mixed cell type 2
Enteric/transitional 1
Signet ring/small cell 1
Total 109
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MMLH1 in high-grade enteric adenocarcinoma of the urinary bladder
Fig. 2B). Tumour cells in the areas with mucinous or signet cell
orphology also reacted positively for cytokeratin 20 (Fig. 2C),
s did epithelial cells in intestinal metaplasia, cystitis glandu-
aris, and tubulovillous adenomas. Seventeen tumours were also
ocally positive for cytokeratin 7. Areas of intestinal metaplasia and
ntestinal-type cystitis glandularis were negative for cytokeratin 7,
hereas uninvolved transitional epithelium or urothelial type cys-
itis glandularis were always positive (Fig. 2D). Nuclear positivity
or CDX2 was observed in all enteric adenocarcinomas, tubulovil-
ous adenomas, and intestinal metaplasia (Fig. 3A and B). Of the 54
umours that were tested for villin expression, 41 (76%) were pos-
tive in both adenocarcinoma and in adenomatous areas. The brush
order localisation of villin in adenomas and low-grade adenocar-
inomas (Fig. 3C) was different from intracytoplasmic reaction in
igh-grade adenocarcinomas (Fig. 3D). The pattern and intensity of
LH1 expression was variable from case to case (Fig. 3E). Overall,
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22% of adenocarcinomas showed a reduction in the nuclear staining
for MLH1 (Fig. 3F).
Discussion
Primary adenocarcinomas of the urinary bladder are uncommon,
comprising about 2% of all bladder cancers [1]. The classification
of adenocarcinomas of the urinary bladder has been the subject
of many publications in the past. Some authors have included
all urothelial carcinomas with recognisable glandular differentia-
tion in the adenocarcinoma category, while others have recognised
only those without an associated transitional carcinoma component
as primary adenocarcinomas of the urinary bladder [1–3,9–11].
Pure non-transitional adenocarcinomas of the bladder include the
enteric-(intestinal) type and the rare clear cell (mesonephric) ade-
nocarcinomas. Primary enteric-type adenocarcinomas of the urinary
bladder can be further divided into urachal and non-urachal varieties.
The urachal type occurs in the dome or anterior wall and commonly
exhibits a mucinous histomorphology [7]. Non-urachal primary ade-
nocarcinomas of the bladder usually occur in the trigone, posterior,
or postero-lateral walls [4–6,8].
The pure non-urachal enteric-type primary adenocarcinomas of
the urinary bladder are relatively rare and, to our knowledge, this is
the largest series (109 cases) of this tumour reported. These tumours
usually occur in association with bladder exstrophy or schisto-
soma associated bladder cancer. Histologically, they may exhibit
an enteric (intestinal/colonic), signet ring cell, or mucinous mor-
phology. When compared to transitional cell carcinomas, enteric
adenocarcinomas of the urinary bladder behave more aggressively,
with the signet ring cell type being associated with an extremely
poor prognosis [12–14].
The possibility of urachal or colonic origin was clinically
excluded in our patients. The majority of tumours showed a classic
enteric (colonic) morphology, some with focal signet ring cell or
mucinous features. Two cases were predominantly mucinous type
and five were composed mostly of signet ring cells. Associated
colonic metaplasia, colonic-type cystitis glandularis, and tubulovil-
lous adenomas – with or without dysplasia – were observed in
about one quarter of cases where adequate tissue was available
for evaluation as well as reported by others [15,16]. The expres-
sion profile of cytokeratin 20, cytokeratin 7, CDX2, villin and
MLH1 closely resembled that of colorectal adenocarcinomas. Areas
with signet ring cell or mucinous morphology exhibited the same
immunohistochemical profile as colonic carcinomas. This simi-
lar immunohistochemical profile of adenocarcinoma of the urinary
bladder and colon may be explained by their common embryogenic
origin from endoderm.
The expression of CDX2, villin, and mismatch repair gene prod-
ucts in colorectal carcinomas has been studied previously. CDX2 is a
homeobox intestinal differentiation factor that regulates the expres-
sion of a number of key intestinal enzymes. Most gastrointestinal
tract adenocarcinomas, particularly those of colonic origin, express
CDX2. Similar to CDX2, villin is also expressed by the majority
of colonic carcinomas. This actin-binding protein is localised in the
microvilli of normal epithelial cells in the small and large intestines
[17]. In well-differentiated colonic adenocarcinomas, villin expres-
sion is seen in the brush border of neoplastic cells; a pattern that
was also observed in our group of enteric adenocarcinomas of the
urinary bladder.
Microsatellite instability is a genetic alteration caused by defects
in mismatch repair genes. The most commonly affected genes – orig-155
nally described in colorectal cancers – are MLH1 and MSH2 [18].
LH1 and MSH2 abnormalities are found in up to 20% of sporadic
olorectal carcinomas [18]. The traditional PCR-based assays for
issue detection of mismatch repair genes have for the most part been
eplaced by simple immunohistochemical identification of their pro-
ein products [19]. In addition to colorectal tumours, abnormality
f mismatch repair genes has been shown in other malignancies,
ncluding those of urothelial origin. In one study, up to 46% of blad-
er carcinomas were shown to have reduced expression of MLH1
y immunohistochemistry [20].
It is generally believed that most cases of primary intestinal-type
denocarcinoma of the urinary bladder arise either from intesti-
al metaplasia or enteric-type cystitis glandularis [3–6,9]. This was
rue in our group of patients, many of whom exhibited such an
ssociation. The morphologic and immunophenotypic similarity of
nteric adenocarcinomas of the urinary bladder and primary col-
rectal adenocarcinomas is further strengthened by the presence of
remalignant stages such as adenomas with dysplasia or in situ and
ntramucosal carcinoma.
Villous adenomas of the urinary bladder have been reported
efore, and it has been postulated that most represent the non-
nvasive phase of intestinal-type adenocarcinomas [21–23]. The
resence of tubulovillous adenomas with varying grades of dyspla-
ia or early invasive carcinoma in our cases supports that impression.
his observation further suggests that intestinal-type adenocarcino-
as of the bladder may follow a carcinogenic pathway similar to
hat observed in colorectal carcinomas. Whether or not the same
ultistep progression of gene abnormality of colorectal cancer can
e detected in intestinal adenocarcinoma of the urinary bladder is
et to be determined.
In summary, enteric adenocarcinoma of the urinary bladder is
istologically similar to colonic adenocarcinoma. All morphologic
ariants may be associated with intestinal metaplasia, enteric-type
ystitis glandularis, and tubulovillous adenomas with dysplasia or
ntramucosal carcinoma. These morphologic, immunohistochem-
cal and genetic abnormalities suggest a common carcinogenetic
athway for enteric adenocarcinoma of the urinary bladder and
olorectal adenocarcinomas.
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